文摘
We have investigated the interaction of VP39, the vaccinia-encodedmRNA cap-specific 2'-O-methyltransferase, with its capped RNA substrate. Twosites on the protein surface, responsible forbinding the terminal cap nucleotide (m7G) and cap-proximalRNA, were characterized, and a third(downstream RNA binding) site was identified. Regarding thecrystallographically defined m7G bindingpocket, VP39 showed significant activity with adenine-capped RNA.Although VP39 mutants lackingspecific m7G-contact side chains within the pocket showedreduced catalytic activity, none was transformedinto a cap-independent RNA methyltransferase. Moreover, eachretained a preference for m7G and Aover unmethylated G as the terminal cap nucleotide, indicating aredundancy of m7G-contact residuesable to confer cap-type specificity. Despite containing the2'-O-methylation site, m7GpppG (capdinucleotide) could not be methylated by VP39, butm7GpppGUbiotinp could. This indicatedthe minimum-length 2'-O-methyltransferase substrate to be eitherm7GpppGp, m7GpppGpN, orm7GpppGpNp. RNA-protein contacts immediately downstream of the m7GpppGmoiety were found to be pH-sensitive. Thiswas detectable only in the context of a weakened interaction ofnear-minimum-length substrates withVP39's m7G binding pocket (through the use of eitheradenine-capped substrate or a VP39 pocket mutant),as a dramatic elevation of KM at pH values above7.5. KM values for substrates with RNAchain lengthsof 2-6 nt were between 160 and 230 nM, but dropped to 9-15 nM uponincreasing chain lengths to20-50 nt. This suggested the binding of regions of the RNAsubstrate >6 nt from the 5' terminus to apreviously unknown site on the VP39 surface.